| P50 | author | Katja Zirlik | Q95969495 |
| P2093 | author name string | Maike Buchner | |
| | Fabio Malavasi | |
| | Rainer Claus | |
| | Justus Duyster | |
| | Michael Reth | |
| | Arlette Dörffel | |
| | Christine Dierks | |
| | Hassan Jumaa | |
| | Hendrik Veelken | |
| | Kathrin Kläsener | |
| | Kerstin Leberecht | |
| | Marco Benkisser-Petersen | |
| | Marcus Dühren-von-Minden | |
| | Meike Burger | |
| P2860 | cites work | CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival | Q24328741 |
| | Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia | Q24599100 |
| | SAR650984, a novel humanized CD38-targeting antibody, demonstrates potent antitumor activity in models of multiple myeloma and other CD38+ hematologic malignancies | Q27690846 |
| | Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22 | Q28216101 |
| | An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia | Q28257366 |
| | Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma | Q28266655 |
| | Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling | Q28272891 |
| | Idelalisib and rituximab in relapsed chronic lymphocytic leukemia | Q28306347 |
| | Ratiometric analysis of fura red by flow cytometry: a technique for monitoring intracellular calcium flux in primary cell subsets | Q28545746 |
| | Identification of the major sites of autophosphorylation of the murine protein-tyrosine kinase Syk | Q28619124 |
| | Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia | Q29620690 |
| | CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated p | Q30442865 |
| | CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells | Q30484805 |
| | Phosphorylation of c-Cbl and p85 PI3K driven by all-trans retinoic acid and CD38 depends on Lyn kinase activity. | Q33690728 |
| | CD38 ligation induces tyrosine phosphorylation of Bruton tyrosine kinase and enhanced expression of interleukin 5-receptor alpha chain: synergistic effects with interleukin 5. | Q33725816 |
| | Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia | Q33873337 |
| | Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. | Q34060896 |
| | CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells. | Q53336736 |
| | Regulation of CD38 in proliferating chronic lymphocytic leukemia cells stimulated with CD154 and interleukin-4. | Q53515550 |
| | CD38 induces differentiation of immature transitional 2 B lymphocytes in the spleen | Q57058811 |
| | CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells | Q57374952 |
| | 4 1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells | Q57584301 |
| | Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia | Q58042064 |
| | CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential | Q61640131 |
| | CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction | Q72201932 |
| | Biochemical analysis of activated T lymphocytes. Protein phosphorylation and Ras, ERK, and JNK activation | Q73577797 |
| | Human CD38 and its ligand CD31 define a unique lamina propria T lymphocyte signaling pathway | Q73644246 |
| | CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment | Q80837099 |
| | E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemia | Q83146478 |
| | Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9 | Q84094990 |
| | Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. | Q34156748 |
| | A critical role of Lyn and Fyn for B cell responses to CD38 ligation and interleukin 5 | Q36585953 |
| | Induction of the transcription factors NF-kappa B, AP-1 and NF-AT during B cell stimulation through the CD40 receptor | Q38299456 |
| | The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells. | Q39404177 |
| | Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia. | Q39834162 |
| | CD38/CD19: a lipid raft-dependent signaling complex in human B cells | Q40165708 |
| | CD38 induces apoptosis of a murine pro-B leukemic cell line by a tyrosine kinase-dependent but ADP-ribosyl cyclase- and NAD glycohydrolase-independent mechanism. | Q40276341 |
| | CD38 is associated with lipid rafts and upon receptor stimulation leads to Akt/protein kinase B and Erk activation in the absence of the CD3-zeta immune receptor tyrosine-based activation motifs. | Q40771031 |
| | Modulator and messenger functions of cyclic ADP-ribose in calcium signaling. | Q41028995 |
| | CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with lyn and phosphatidylinositol 3-kinase | Q41103086 |
| | Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression | Q41175199 |
| | CD38 signal transduction in human B cell precursors. Rapid induction of tyrosine phosphorylation, activation of syk tyrosine kinase, and phosphorylation of phospholipase C-gamma and phosphatidylinositol 3-kinase | Q41254178 |
| | Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration | Q42221150 |
| | Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia | Q43119715 |
| | Clinical significance of CD38 expression in chronic lymphocytic leukemia | Q43775864 |
| | CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome? | Q53322008 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0169159 | |
| P577 | publication date | 2016-12-30 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia | |
| P478 | volume | 11 | |